Micron Technology: I Think There Is A Clear Path To Over $1,500

Micron is described as deeply undervalued at 11x forward P/E despite 190% YoY revenue growth and a 57% net income margin. The rerating case is driven by structural AI demand, fully committed 2026 HBM capacity, and leadership in SOCAMM2, HBM4, and the 1-gamma DRAM node. Micron is also confirmed as a supplier for NVIDIA's Vera Rubin platform with high-volume HBM4 and SOCAMM2 shipments.

Analysis

MU is transitioning from a cyclical memory name into a capacity-constrained AI infrastructure supplier, and that changes the valuation framework more than the headline multiple suggests. The real wedge is not just margin expansion, but the duration of those margins: once advanced HBM capacity is effectively sold out into 2026, pricing power becomes a function of execution rather than market demand, which lowers earnings volatility and justifies a structurally higher multiple.

The second-order winner is NVDA, but not because it gets cheaper components; rather, MU de-risks NVDA’s platform rollout by expanding the addressable supply of advanced memory. That should also pressure weaker DRAM competitors whose capex was built for a different mix, forcing them into either catch-up spend or share loss. The supply chain implication is tighter allocation for commodity DRAM and potentially better gross margin discipline across the memory complex if AI demand continues to absorb leading-edge wafers.

The key risk is timing mismatch: the market is likely to extrapolate 2026 capacity and 1-gamma ramps into near-term earnings, while actual upside may arrive in steps over multiple quarters. Any slowdown in hyperscaler AI capex, a node yield issue, or a delay in next-gen platform adoption could trigger a sharp de-rating because the stock is now priced on flawless execution rather than distressed cyclicality.

Consensus still appears to underappreciate how much of this story is about scarcity, not growth. If HBM remains allocated and 1-gamma improves die cost per bit, MU can sustain elevated returns even if revenue growth moderates, meaning the upside case is less about peak growth and more about persistent FCF conversion. That makes the current rerating potentially underdone, but it also means the stock will be sensitive to any sign that supply is catching up faster than demand.

Key Decisions for Investors

• Go long MU on pullbacks, with a 3-6 month horizon; target a re-rating toward low-to-mid teens forward P/E as the market prices in 2026 HBM scarcity, but keep a tight stop if AI capex breadth weakens.
• Pair trade: long MU / short a weaker DRAM competitor basket for 6-12 months; the edge is capacity mix and process-node leadership, while the short leg captures any normalization in commodity memory pricing.
• For NVDA holders, use MU as a lower-beta expression of the same AI buildout and a hedge against any temporary GPU multiple compression; prefer MU for exposure to memory bottlenecks rather than compute valuation.
• Buy MU call spreads 3-6 months out to express upside with defined risk; best setup is into any post-earnings volatility when the market discounts the 2026 capacity ramp too slowly.
• Trim or hedge MU if there is evidence of HBM allocation loosening or if hyperscaler capex guide cuts emerge; the stock’s rerating is most vulnerable to any sign that the supply constraint is easing before demand does.